Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-23-033143

Chief Scientific Officer acquired 53,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kidron Miriam Chief Scientific Officer 2023-05-26 Grant or award +53,500 468,166 D
Loading xslF345X04/doc4.xml…